SK

Sushil Kumar Shyamsunder Mishra

Active Director Director DIN 09119202
DIN 09119202 First appointment Aug 2025 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Sushil Kumar Shyamsunder Mishra

Data last updated:

Sushil Kumar Shyamsunder Mishra is a Director at Shinsei Pharmaceuticals Private Limited (since 2025). The company operates in Pharma.

DIN 09119202
Primary Designation Director
Industry Pharma
First Appointment 29 Aug 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director29 Aug 20252025Active

Board colleagues of Sushil Kumar Shyamsunder Mishra

Directorship timeline

Open interactive timeline →
Shinsei Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Sushil Kumar Shyamsunder Mishra

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sushil Kumar Shyamsunder Mishra

Sushil Kumar Shyamsunder Mishra currently holds 1 directorship: Shinsei Pharmaceuticals Private Limited (Director, since 29 Aug 2025).

Sushil Kumar Shyamsunder Mishra was first appointed on 29 Aug 2025 as Director at Shinsei Pharmaceuticals Private Limited.

The current boards of Sushil Kumar Shyamsunder Mishra's companies include Shivpoojan Sarvajeet Pandey (Shinsei Pharmaceuticals Private Limited), Shweta Parmanand Singh (Shinsei Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available